Increase in Clostridium difficile-related mortality rates, United States, 1999-2004. - Wikidata - awgldk - TriplyDB

Increase in Clostridium difficile-related mortality rates, United States, 1999-2004.

Increase in Clostridium difficile-related mortality rates, United States, 1999-2004.

http://www.wikidata.org/entity/Q33800946

about

Antibiotic treatment for Clostridium difficile -associated diarrhea in adults Amixicile, a novel inhibitor of pyruvate: ferredoxin oxidoreductase, shows efficacy against Clostridium difficile in a mouse infection model.Bench-to-bedside review: Clostridium difficile colitis Toxin B is essential for virulence of Clostridium difficile Diagnosis and treatment of acute or persistent diarrhea Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal Effects Recent advances in the understanding of antibiotic resistance in Clostridium difficile infection Acid suppression and the risk of Clostridium difficile infection Current Trends in the Epidemiology and Outcomes of Clostridium difficile Infection Diagnosis of Clostridium difficile Infections in Children Clostridium difficile infection: An overview of the disease and its pathogenesis, epidemiology and interventions Antibiotic treatment for Clostridium difficile-associated diarrhoea in adults.Delirium and other clinical factors with Clostridium difficile infection that predict mortality in hospitalized patients.Clostridium difficile ribotype 027 is most prevalent among inpatients admitted from long-term care facilities.Survey of C. difficile-Specific Infection Control Policies in Local Long-Term Care Facilities Ribotype 027 Clostridium difficile infections with measurable stool toxin have increased lactoferrin and are associated with a higher mortality Diarrhea, clostridium difficile, and intestinal inflammation in residents of a long-term care facility.The analysis of para-cresol production and tolerance in Clostridium difficile 027 and 012 strains.A mariner-based transposon system for in vivo random mutagenesis of Clostridium difficile.Postoperative Clostridium difficile-associated diarrhea.Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile.Genome mining for radical SAM protein determinants reveals multiple sactibiotic-like gene clusters.Preoperative risk factors for postoperative Clostridium difficile infection in colectomy patients.The role of toxin A and toxin B in Clostridium difficile-associated disease: Past and present perspectives.Epidemiology of Clostridium difficile infection Lack of association of outcomes with treatment duration and microbiologic susceptibility data in Clostridium difficile infections in a non-NAP1/BI/027 setting.Inhibiting the initiation of Clostridium difficile spore germination using analogs of chenodeoxycholic acid, a bile acid.Current status of Clostridium difficile infection epidemiology An optimized, synthetic DNA vaccine encoding the toxin A and toxin B receptor binding domains of Clostridium difficile induces protective antibody responses in vivo The association between histamine 2 receptor antagonist use and Clostridium difficile infection: a systematic review and meta-analysis.A hospital-based study of the clinical characteristics of Clostridium difficile infection in children.Identification of a genetic locus responsible for antimicrobial peptide resistance in Clostridium difficile Characterisation of Clostridium difficile biofilm formation, a role for Spo0A.Association between proton pump inhibitor therapy and clostridium difficile infection: a contemporary systematic review and meta-analysis.Procalcitonin levels associate with severity of Clostridium difficile infection Clostridium difficile: progress and challenges.Trends in gastroenteritis-associated mortality in the United States, 1985-2005: variations by ICD-9 and ICD-10 codes.Treatment of Clostridium difficile infection: recent trial results.Hypoxia-inducible factor signaling provides protection in Clostridium difficile-induced intestinal injury.Bile acid recognition by the Clostridium difficile germinant receptor, CspC, is important for establishing infection.

P2860

Q24234378-7E3D46A8-A9ED-43C5-8BE4-C567D4D878CE Q24616179-30985708-CAD1-427B-8335-371768FBBC75 Q24644191-01CD7384-5E0C-42D2-8084-02510AB5D7CF Q24647539-1182C443-C9A6-40CA-88A6-08512AB3ABB9 Q24654895-CF1D4BFE-9679-45BF-90E8-C550EBEB0035 Q26751477-8F4ACE70-A8E4-4635-A87C-414FCD9D2BF3 Q26767079-1158B067-74F0-48EF-AA74-2B5437A51211 Q26823599-FC32F205-D8CC-4203-8963-D660A8F0D544 Q26996462-1F755212-EDB0-4709-8DFF-31D774F0B220 Q28075324-335D1E82-5F71-4AF0-B4D9-D9A8B25481E5 Q28743438-51EB1790-C804-4BC1-961B-222A3C6EE739 Q30235446-CF3E82A0-7EF0-42EA-912F-607A7AB30254 Q30300033-8F73674C-DCB7-4E01-AEC1-119AEDD11045 Q30365997-41E773BD-500D-498E-BA45-DA3D1EEFC935 Q30412521-5CD3C077-B045-44BD-AD03-910103174CB4 Q30413111-A751D687-B7AA-49CD-B51A-8C1DA73D8790 Q30436153-56D990D2-4083-46ED-B044-C2EDFAF1BE24 Q30475404-E78549D2-D1F5-4FAB-A7B3-38AA0FFA47E9 Q33519869-2D464305-3C37-4517-BA1D-51AF96A994F0 Q33915343-4B4BF069-C3CD-4996-8369-0E7F294A1BC1 Q33927147-758CEA22-81DB-465E-A363-09F4F78ADB25 Q33961416-D1BF4C81-CC78-420C-B636-C04D18EA4672 Q33993544-6D9D7A15-CA46-4A70-952A-A9F0D54E0563 Q34006236-A7EEDA03-6FD2-4FE1-86A9-1F00D0DDFFC0 Q34027474-20DECC5C-85AB-4162-BDC9-571E09634281 Q34072892-6F790EF4-3127-476E-8638-E9028A20316C Q34150754-19956949-B051-4F7F-BEC3-5211E8D9B75C Q34285444-021D0C2E-57D9-4387-9364-5FE19F5823CB Q34298763-3E55CEF6-3F52-434B-AB71-567817BBC55F Q34331595-5A701632-FA1A-4A76-BCAB-C67EE5A59698 Q34440654-7EBD49ED-7B01-4508-8391-6CC3AE124FDE Q34484594-EF3218B7-CFFC-4471-AE23-1EA13AF485F8 Q34510386-ED36A948-5DDA-4112-8FC2-781ABFFB1447 Q34510524-937ADA8C-AC70-4703-8EF6-02FFD19E9988 Q34625689-849096AE-C5B6-47F1-A5A4-F3BC73745972 Q34625939-638BC81E-E6B7-4645-A4F5-0F4305619554 Q34707949-ACB5A638-49B3-4D4D-8F89-1AEDECB12461 Q34710368-2CF3D709-B08E-4A87-8D7C-08FC6A96F741 Q34717238-B793F066-B014-491B-9E54-A234995B6BFF Q34722536-189E34A5-0515-463B-A34B-7129A54D5FDA

P2860

Increase in Clostridium difficile-related mortality rates, United States, 1999-2004.

http://www.wikidata.org/entity/Q33800946

description

2007 nî lūn-bûn

@nan

2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Increase in Clostridium difficile-related mortality rates, United States, 1999-2004.

@ast

Increase in Clostridium difficile-related mortality rates, United States, 1999-2004.

@en

type

label

Increase in Clostridium difficile-related mortality rates, United States, 1999-2004.

@ast

Increase in Clostridium difficile-related mortality rates, United States, 1999-2004.

@en

prefLabel

Increase in Clostridium difficile-related mortality rates, United States, 1999-2004.

@ast

Increase in Clostridium difficile-related mortality rates, United States, 1999-2004.

@en

P1433

Q33800946-4401CF5A-2DFC-4AB3-9DCE-24D6011F2380

P1476

Q33800946-94D7D8DA-E643-4825-AA8A-76C271B7C9BE

P2093

Q33800946-3BA2D244-9FD1-421B-8E57-5CA5219AD11C

Q33800946-AE6266A0-F669-447B-9383-3C073967E5FC

Q33800946-B125FDEA-2E76-43FC-8FAC-9AE32711F62C

P2860

Q33800946-172D6677-61D8-4297-9857-611E601274DC

Q33800946-1B83B62F-2AC6-4341-A939-2174E4206243

Q33800946-20674001-82E1-4B88-8929-814D92474486

Q33800946-3F2D004F-445B-4A83-9C89-07D9485B13F3

Q33800946-67C86B04-7527-4274-AC5A-51959501816D

Q33800946-814E925F-1DD4-4543-A7FD-5DA6E5698F21

Q33800946-89EB9701-C5B1-47DA-97DA-126605D09659

Q33800946-9561F25E-EB63-4C46-AFA6-C10DD32A3A0C

Q33800946-A708A918-BBBD-4C62-A292-52D7D5F37FED

Q33800946-B42561A2-9D86-428F-979C-B5A7E727F1B9

P304

Q33800946-B530B847-D101-4EAD-92F6-EFB4D4BE50D0

P31

Q33800946-554062A0-2BA3-489B-A3E6-8110639B4EF8

P356

Q33800946-97CE70EA-8485-4E33-B011-4AE0522C947E

P433

Q33800946-EA28C1E0-871C-49BC-BFB3-1505B75F9068

P478

Q33800946-BE8DED96-75FA-437D-95ED-FADF33E6A748

P577

Q33800946-F1E369F5-9703-4A3C-88D6-282A18A7C6C5

P5875

Q33800946-2C934C21-8254-4C19-93AB-32CE1A144A7C

P698

Q33800946-077CC617-3373-44F8-9A9B-71D875842AA0

P921

Q33800946-C22C0FB7-1773-42D8-AAFC-CD68D0F58A3A

Q33800946-F7AC3E48-AEE6-4C7E-AF52-87F7C322E44B

P932

Q33800946-6AEA0244-36BC-438A-9F42-55BE48CCD964

P356

P1433

Emerging Infectious Diseases

P1476

Increase in Clostridium difficile-related mortality rates, United States, 1999-2004.

@en

P2093

Frank Sorvillo

http://www.w3.org/2001/XMLSchema#string

Laurene Mascola

http://www.w3.org/2001/XMLSchema#string

Matthew D Redelings

http://www.w3.org/2001/XMLSchema#string

P2860

Epidemiology of Clostridium difficile-associated infections.

Risk factors for Clostridium difficile infection.

Are broad-spectrum fluoroquinolones more likely to cause Clostridium difficile-associated disease?

Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use.

Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity.

Bacterial diarrhea in persons with HIV infection, United States, 1992-2002.

Emergence of Clostridium difficile-associated disease in North America and Europe.

Clostridium difficile colitis.

Age standardization of death rates: implementation of the year 2000 standard.

Increase in deaths related to enterocolitis due to Clostridium difficile in the United States, 1999-2002.

P304

1417-1419

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3201/EID1309.061116

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2007-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5600388

http://www.w3.org/2001/XMLSchema#string

P698

18252127

http://www.w3.org/2001/XMLSchema#string

P921

Ameeriga Ütisriigiq

Clostridium difficile

P932

2857309

http://www.w3.org/2001/XMLSchema#string